Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,887 | 108,419 | 81,698 | 194,494 | 31,569 |
| Marketable Securities | 51,607 | 57,002 | N/A | 34,982 | 184,320 |
| Receivables | 28,896 | 20,773 | 9,670 | N/A | N/A |
| Inventories | 3,170 | 2,625 | 2,029 | N/A | N/A |
| Other current assets | 477 | 1,787 | 0 | 0 | 0 |
| TOTAL | $166,296 | $203,003 | $106,394 | $236,474 | $223,549 |
| Non-Current Assets | |||||
| PPE Net | 3,304 | 3,963 | 4,470 | 5,153 | 2,383 |
| Intangibles | 40,461 | 44,408 | 48,355 | 0 | 0 |
| Other Non-Current Assets | 24,844 | 7,748 | 6,306 | 11,163 | 13,910 |
| TOTAL | $68,609 | $56,119 | $59,131 | $16,316 | $16,293 |
| Total Assets | $234,905 | $259,122 | $165,525 | $252,790 | $239,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,183 | 20,684 | 27,692 | 20,035 | 17,803 |
| Accrued Expenses | 69,030 | 46,431 | 30,648 | 17,426 | 14,639 |
| TOTAL | $90,837 | $67,115 | $58,340 | $37,461 | $32,442 |
| Non-Current Liabilities | |||||
| Long Term Debt | 94,962 | 151,886 | 48,477 | N/A | N/A |
| Other Non-Current Liabilities | 31,643 | 0 | 0 | 0 | 0 |
| TOTAL | $126,605 | $157,701 | $53,883 | $5,505 | $1,393 |
| Total Liabilities | $217,442 | $224,816 | $112,223 | $42,966 | $33,835 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,302 | 38,498 | 37,720 | 36,952 | 32,487 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -1,277,636 | -1,202,041 | -1,088,466 | -796,511 | -520,500 |
| Other shareholders' equity | 62 | -12 | -449 | -13 | -147 |
| TOTAL | $17,463 | $34,306 | $53,302 | $209,824 | $206,007 |
| Total Liabilities And Equity | $234,905 | $259,122 | $165,525 | $252,790 | $239,842 |